These results clearly demonstrate that DP84GGPM87 can constitutively present peptides derived from both intracellular and extracellular tumour-associated antigens and is directly recognized by antigen-specific CD4+ T cells in a CLIP-independent manner. Here, CD4 is linked to neoplasm.